MagForce AG (MGFRF) Research

MagForce AG focuses on innovative nanotechnology-driven cancer therapy, with operations spanning Germany and Poland. The company's key offerings include NanoTherm, a therapeutic solution for brain tumors; NanoPlan, specialized software designed to assist medical professionals in crafting optimal treatment strategies for NanoTherm; and the NanoActivator, a device engineered to generate magnetic fields. Established in 1997, MagForce AG maintains its primary office in Berlin, Germany.

Market snapshot

Symbol
MGFRF
Price
$0.00
Day change
0.00%
Market cap
$3.5M
P/E ratio
-329.76x
52-week range
4.0E-4-0.001
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Acorda Therapeutics, Inc. (ACORQ)
  • Allied Healthcare Products, Inc. (AHPIQ)
  • Advanzeon Solutions, Inc. (CHCR)
  • Goodbody Health Limited (GDBYF)
  • Genesis Healthcare, Inc. (GENN)
  • Generex Biotechnology Corporation (GNBT)
  • MobileSmith, Inc. (MOSTQ)
  • Navidea Biopharmaceuticals, Inc. (NAVB)

Open MagForce AG (MGFRF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.